Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Large Volume Increase - Time to Buy?

Key Points

• Trading volume spike: Shares traded about 93,243 shares on Thursday, a roughly 23% increase from the prior session, with the stock last trading near $12.94 (prior close $13.02).
• Analyst sentiment: Wall Street has a consensus Buy rating (three Buy ratings), including a Citigroup reissue of Buy and Morgan Stanley's Overweight call.
• Key fundamentals: Market cap ~$29.5B, P/E ~20.8 and debt/equity 0.49; latest quarter EPS $0.28 on $6.94B revenue, with analysts forecasting ~0.79 EPS for the year.

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 93,243 shares were traded during trading, an increase of 23% from the previous session's volume of 75,677 shares.The stock last traded at $12.9350 and had previously closed at $13.02.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on FSNUY shares. Citigroup reissued a "buy" rating on shares of Fresenius SE & Co. in a report on Tuesday, February 3rd. Morgan Stanley reiterated an "overweight" rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Fresenius SE & Co. presently has a consensus rating of "Buy".

Fresenius SE & Co. Trading Up 0.6%

The business has a 50 day simple moving average of $13.96 and a 200-day simple moving average of $14.32. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.99 and a current ratio of 1.26. The stock has a market capitalization of $29.51 billion, a P/E ratio of 20.79 and a beta of 0.81.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.28 EPS for the quarter. The company had revenue of $6.94 billion for the quarter. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%. On average, analysts predict that Fresenius SE & Co. will post 0.79 EPS for the current year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world's leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.